Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

ABCs Report: Methicillin-Resistant Staphylococcus aureus, 2008

Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network

Print-friendly version of this surveillance report [44 KB, 1 page]

ABCs Areas

California (3 county San Francisco Bay area); Colorado (5 county Denver area); Connecticut; Georgia (8 county Atlanta area); Maryland (1 county Baltimore area); Minnesota (2 metro Twin City counties); New York (1 Rochester county); Oregon (3 county Portland area); Tennessee (1 Nashville county).   Note the population under surveillance changed from 2007 (bold).

ABCs Population

The surveillance areas represent 19,086,261 persons.
Source: National Center for Health Statistics bridged-race vintage 2008 postcensal file.

ABCs Case Definition

Invasive methicillin-resistant Staphylococcus aureus (MRSA) disease:  isolation of MRSA from a normally sterile site in a resident of the surveillance area in 2008. Cases of disease are classified into one of three epidemiologic classifications. A case is classified as hospital-onset (HO) if the MRSA infection was identified more than 2 days after hospital admission;  as healthcare-associated community-onset (HACO) if the MRSA infection was identified 2 or fewer days after admission and had one of more of the following: 1) a history of hospitalization, surgery, dialysis or residence in a long term care facility in the previous year, or 2) the presence of a central vascular catheter.  If none of the previously mentioned criteria are met, a case is classified as community-associated (CA)†.

ABCs Methodology

ABCs personnel routinely contacted all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that collect demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. Selected isolates were collected and sent to CDC for routine testing including: antimicrobial susceptibility testing, toxin testing and SCCmec typing. Pulsed field gel electrophoresis (PFGE) was discontinued in 2008. An Inferred PFGE Algorithm based on molecular characteristics of an isolate has been validated for the use with isolates collected though this surveillance only (http://www.cdc.gov/HAI/settings/lab/inferred-PFGE-algorithm.html). Regular laboratory audits assessed completeness of active surveillance and detected additional cases.

Rates of  invasive MRSA disease were calculated using  population estimates for 2008.  For national estimates of cases, race- and age-specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 2008 U.S. population. Cases with unknown race were distributed by site based on reported race distribution for known cases.

Epidemiological Classification Definition Changes
Previous documented MRSA colonization or infection is not a determinant in classifying patients, unlike previously published estimates which include such patients in the HACO category. HO cases are now defined based on reported calendar dates (i.e. greater than "48 hours") this also differs from previously published estimates. (JAMA, 2007 Oct 17; 298 (15): 1765-71)

Reported ABCs Profiles

Race No. (Rate*)
White 3256 (24.5)
Black 2002 (60.1)
Other 222 (13.2)

Unknown race (n=771) distributed amongst known

* Cases per 100,000 population for ABCs areas

MRSA Class No. (Rate*)
Cases^
No. (Rate*)
Deaths˜
Inferred PFGE Type (N,%)
Tot N±
Inferred PFGE Type (N,%)
USA100±
Inferred PFGE Type (N,%)
USA300±
HO 1276 (6.7) 304 (1.6) 247 177 (71.7) 48 (19.4)
HACO 3203 (16.8) 481 (2.5) 585 363 (62.1) 157 (26.8)
CA 929 (4.9) 91 (0.5) 151 46 (30.5) 103 (68.2)

*Cases per 100,000 population for ABCs areas
^n=151 ˜n=20; could not be classified after chart review
±1351 isolates were eligible for testing up receipt to CDC, 1005 have Inferred PFGE algorithm, 13 will require direct PFGE

Syndrome CA
(n=929)
HACO
(n=3203)
HO
(n=1276)
Bloodstream Infection with other syndrome 512 2143 862
Bloodstream Infection with no other syndrome 158 987 521
Pneumonia 155 459 232
Osteomyelitis 122 322 105
Endocarditis 94 195 45
Cellulitis 168 273 55
Skin abscess* 11 28 13

Note: Some cases had more than one syndrome.

*Category includes skin abscess, necrotizing fasciitis, gangrene, wounds

National Estimates of Invasive Disease

Cases: 89,785 (29.53/100,000)
Deaths: 15,249 (5.02/100,000)

Citation

Centers for Disease Control and Prevention. 2008. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008. 

Available via the Internet: http://www.cdc.gov/abcs/reports-findings/survreports/mrsa08.pdf

Top of Page

External Web Site Policy This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.

File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)

Copyrighted images: Images on this website which are copyrighted were used with permission of the copyright holder and are not in the public domain. CDC has licensed these images for use in the materials provided on this website, and the materials in the form presented on this website may be used without seeking further permission. Any other use of copyrighted images requires permission from the copyright holder.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #